Login
$PODD
$145.29 -$7.19 (4.72%) Live

$PODD SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G
13 Nov 2026 SCHEDULE 13G
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

ACTON, Mass. - November 4, 2026 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three...

27 Oct 2026 SCHEDULE 13G/A
05 Oct 2026 Form 4: Pease Flavia, EVP & CFO

Gave up 1,882 shares to cover exercise price or tax ($246K)

02 Oct 2026 Form 4: Mazelsky Jonathan Jay, Director

Received 141 shares as a grant or award ($18.4K)

02 Oct 2026 Form 4: Huffines Robert Luther, Director

Received 178 shares as a grant or award ($23.2K)

21 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

NINTH AMENDMENT (this “Agreement”), dated as of September 21, 2026, among INSULET CORPORATION, a Delaware corporation (the “Borrower”), each Guarantor party hereto, the Lenders party hereto, each L/C Issuer and Swingline Lender party her...

16 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

Section 1.1Establishment. Insulet Corporation (“Insulet”) hereby establishes the Insulet Nonqualified Deferred Compensation Plan (the “Plan”), effective January 1, 2027, for the benefit of select management or highly compensated employee...

10 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

24 Aug 2026 Form 4: McEvoy Ashley, Director

Bought 1,100 shares ($162K)

06 Aug 2026 SCHEDULE 13G/A
05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition

ACTON, Mass. - August 5, 2026 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three m...

04 Aug 2026 Form 4: Davis Lisa Blair, SVP, Chief HR Officer

Gave up 244 shares to cover exercise price or tax ($40.3K)

07 Jul 2026 Form 4/A: Huffines Robert Luther, Director

Received 151 shares as a grant or award ($23K)

02 Jul 2026 Form 4: Mazelsky Jonathan Jay, Director

Received 1,355 shares as a grant or award

02 Jul 2026 Form 3: Mazelsky Jonathan Jay, Director

Holds 0 shares of Common Stock

02 Jul 2026 Form 4: Huffines Robert Luther, Director

Received 144 shares as a grant or award ($23K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support